Abstract
AbstractThe spike protein (S) of SARS-CoV-2 is responsible for viral attachment and entry, thus a major factor for host susceptibility, tissue tropism, virulence and pathogenicity. The S is divided with S1 and S2 region, and the S1 contains the receptor-binding domain (RBD), while the S2 contains the hydrophobic fusion domain for the entry into the host cell. Numerous host proteases have been implicated in the activation of SARS-CoV-2 S through various cleavage sites. In this article, we review host proteases including furin, trypsin, transmembrane protease serine 2 (TMPRSS2) and cathepsins in the activation of SARS-CoV-2 S. Many betacoronaviruses including SARS-CoV-2 have polybasic residues at the S1/S2 site which is subjected to the cleavage by furin. The S1/S2 cleavage facilitates more assessable RBD to the receptor ACE2, and the binding triggers further conformational changes and exposure of the S2’ site to proteases such as type II transmembrane serine proteases (TTPRs) including TMPRSS2. In the presence of TMPRSS2 on the target cells, SARS-CoV-2 can utilize a direct entry route by fusion of the viral envelope to the cellular membrane. In the absence of TMPRSS2, SARS-CoV-2 enter target cells via endosomes where multiple cathepsins cleave the S for the successful entry. Additional host proteases involved in the cleavage of the S were discussed. This article also includes roles of 3C-like protease inhibitors which have inhibitory activity against cathepsin L in the entry of SARS-CoV-2, and discussed the dual roles of such inhibitors in virus replication.
Funder
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference142 articles.
1. Abdelnabi, R., C.S. Foo, D. Jochmans, L. Vangeel, S. De Jonghe, P. Augustijns, R. Mols, B. Weynand, T. Wattanakul, R.M. Hoglund, J. Tarning, C.E. Mowbray, P. Sjo, F. Escudie, I. Scandale, E. Chatelain, and J. Neyts. 2022. The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern. Nature Communications 13: 719. https://doi.org/10.1101/2021.11.04.467077.
2. Acland, H.M., L.A. Silverman Bachin, and R.J. Eckroade. 1984. Lesions in broiler and layer chickens in an outbreak of highly pathogenic avian influenza virus infection. Veterinary Pathology 21: 564–569. https://doi.org/10.1177/030098588402100603.
3. Bailey, A.L., O. Dmytrenko, L. Greenberg, A.L. Bredemeyer, P. Ma, J. Liu, et al. 2021. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 mMyocarditis. JACC: Basic to Translational Science 6: 331–345.
4. Baron, J., C. Tarnow, D. Mayoli-Nüssle, E. Schilling, D. Meyer, M. Hammami, et al. 2013. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses. Journal of Virology 87: 1811–1820. https://doi.org/10.1128/jvi.02320-12.
5. Beaulieu, A., É Gravel, A. Cloutier, I. Marois, É Colombo, A. Désilets, et al. 2013. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium. Journal of Virology 87: 4237–4251. https://doi.org/10.1128/jvi.03005-12.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献